Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAWJH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,186
Award facts
- Contract value 100% obligated
- $33,186.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,186.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 9, 2025, for the supply of Dupixent 300 mg/2 ml pens. The delivery order operates under a firm fixed-price structure with no set-aside designation and carries an ultimate completion date of September 10, 2025. The place of performance is listed as Conshohocken, PA. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group, based in Park Ridge, Illinois, and registered in SAM.gov since 2001, serves as a critical supplier in the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare facilities. Through its Indefinite Delivery Contract with the Defense Logistics Agency, the company provides firm fixed-price delivery orders for an extensive portfolio of pharmaceutical items including injections, tablets, creams, auto-injectors, and specialty medications, positioning it as a key provider of direct pharmaceutical distribution and pharmacy services to military health systems.
Quick answers
Who was awarded contract SPE2DB25FAWJH?
SPE2DB25FAWJH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FAWJH worth?
The government has obligated $33,186 on SPE2DB25FAWJH.
Is contract SPE2DB25FAWJH an order under another contract?
Yes. SPE2DB25FAWJH is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWJH competed?
The extent of competition for SPE2DB25FAWJH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award